KMT2A - lysine methyltransferase 2A Gene

Also Known as MLL

Species: Felis catus

Gene Type: protein coding
Gene ID: 101090288

KMT2A Products (1)

mRNA Protein Name
XM_011286446.4 XP_011284748.3 LOW QUALITY PROTEIN: histone-lysine N-methyltransferase 2A
Protein Preferred Names Protein Names

LOW QUALITY PROTEIN: histone-lysine N-methyltransferase 2A

  • myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-148669 Bleximenib 99.36% Phase 2
HY-148669A Bleximenib oxalate 98.97% Phase 2

Pre-clinical Phase

Bioactive Molecules (9)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-156794 Enzomenib Inhibitor 99.88% Unkown
HY-172416 Balomenib Inhibitor 99.81% Unkown
HY-148669B (S)-Bleximenib oxalate Control 98.37% Unkown
HY-156794A Enzomenib enantiomer Inhibitor 98.01% Unkown
HY-148829 MS40 Degrader / Unkown
HY-170832 Menin–KMT2A-IN-1 Inhibitor / Unkown
HY-RS07401 KMT2A Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS18528 Kmt2a Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS25010 Kmt2a Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens KMT2A NCBI NCBI:4297